SynthesisEuropean journal of cancer (Oxford, England : 1990)2019

Evaluation of objective response, disease control and progression-free survival as surrogate end-points for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials.

Run-Cong Nie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.